Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
584 hedge funds and large institutions have $11.1B invested in Exact Sciences in 2023 Q1 according to their latest regulatory filings, with 99 funds opening new positions, 191 increasing their positions, 185 reducing their positions, and 56 closing their positions.
83% more funds holding in top 10
Funds holding in top 10: 6 → 11 (+5)
77% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 56
38% more capital invested
Capital invested by funds: $8.08B → $11.1B (+$3.06B)
6% more funds holding
Funds holding: 552 → 584 (+32)
3% more repeat investments, than reductions
Existing positions increased: 191 | Existing positions reduced: 185
1% more call options, than puts
Call options by funds: $98.4M | Put options by funds: $97.3M
0.13% more ownership
Funds ownership: 92.15% → 92.27% (+0.13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$399M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$170M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$92.1M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$40.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$38.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$300M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$207M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$102M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$102M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$69.5M |
EXAS Hedge Fund Activity: Q1 2023 in Review
584 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2023, worth a combined $11.1B — up 38% from $8.08B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new EXAS positions and 56 closed out — a net gain of 43 holders — while 191 added to existing stakes and 185 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $399M. The largest seller was ARK Investment Management, cutting an estimated $300M.
- 584 institutional investors held Exact Sciences (EXAS) as of Q1 2023, up from 552 in Q4 2022.
- Funds reported $11.1B of Exact Sciences stock for Q1 2023, up 38% quarter-over-quarter.
- 99 funds opened new Exact Sciences positions in Q1 2023 and 56 closed out, a net change of +43 holders.
- The largest Exact Sciences buyer in Q1 2023 was JP Morgan Chase, an estimated $399M added.
- The largest Exact Sciences seller in Q1 2023 was ARK Investment Management, an estimated $300M sold.
Based on aggregated 13F filings for Q1 2023.